Ironwood Pharmaceuticals Files Q1 2025 10-Q

Ticker: IRWD · Form: 10-Q · Filed: May 12, 2025 · CIK: 1446847

Ironwood Pharmaceuticals Inc 10-Q Filing Summary
FieldDetail
CompanyIronwood Pharmaceuticals Inc (IRWD)
Form Type10-Q
Filed DateMay 12, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, pharmaceuticals

TL;DR

**Ironwood Pharma Q1 2025 10-Q is IN. Check financials.**

AI Summary

Ironwood Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and operations. Key financial data and operational highlights are presented within this report.

Why It Matters

This filing provides investors and analysts with the latest financial and operational data for Ironwood Pharmaceuticals, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Ironwood is subject to regulatory, clinical, and market risks inherent in drug development and commercialization.

Key Numbers

  • 20250331 — Period End Date (Financial reporting period)
  • 20250512 — Filing Date (Date the report was submitted to the SEC)

Key Players & Entities

  • IRONWOOD PHARMACEUTICALS INC (company) — Filer
  • 0001446847 (company) — Central Index Key
  • 20250331 (date) — Period of Report
  • 20250512 (date) — Filed as of Date
  • 100 SUMMER STREET, SUITE 2300 (address) — Business Address
  • BOSTON (location) — Business Address City
  • MA (location) — Business Address State
  • 02110 (zip_code) — Business Address Zip
  • 617-621-7722 (phone_number) — Business Phone

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20250331, meaning the filing covers the period ending March 31, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed as of date 20250512.

What is Ironwood Pharmaceuticals' Central Index Key (CIK)?

Ironwood Pharmaceuticals' Central Index Key is 0001446847.

Where is Ironwood Pharmaceuticals, Inc. headquartered?

Ironwood Pharmaceuticals, Inc. is located at 100 Summer Street, Suite 2300, Boston, MA 02110.

What is the Standard Industrial Classification (SIC) code for Ironwood Pharmaceuticals?

The SIC code for Ironwood Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.